Smiths Group PLC Directors' Change in Responsibilities

RNS Number : 9572E

Smiths Group PLC

29 February 2024

 

29 February 2024

SMITHS GROUP PLC ("Smiths")

 

DIRECTORS' CHANGE IN RESPONSIBILITIES

 

As previously communicated, as part of orderly succession planning, Bill Seeger will retire from the Board of Smiths on 31 May 2024 at which point Mark Seligman will take over as the Senior Independent Director. In anticipation of Bill Seeger's retirement, he resigned as Smiths nominated Director on the Board of ICU Medical Inc. with effect from 28 February 2024.

 

Smiths Chair Steve Williams said: "I would like to take this opportunity to thank Bill for his many contributions to Smiths and for supporting me since my appointment to the Board. I also look forward to continuing to work with Mark in his new capacity as the Senior Independent Director."

 

There is no further information required to be disclosed pursuant to LR 9.6.11.

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

 

Enquiries:

Investor enquiries	Media enquiries
Siobhán Andrews, Smiths Group [phone] [e-mail]	Tom Steiner, Smiths Group [phone] [e-mail]
Company Secretary
Matthew Whyte [phone] [e-mail]

 

About Smiths Group

 

For over 170 years, Smiths Group has been pioneering progress by improving our world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient, and better-connected world, across four major global markets:  Energy, General Industry, Safety & Security and Aerospace. Listed on the London Stock Exchange, Smiths employs more than 15,000 colleagues in over 50 countries. For more information visit www.smiths.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BOASEFSAUELSEIE